Pervasis Therapeutics Secures $9,750,000 New Funding

  • Feed Type
  • Date
  • Company Name
    Pervasis Therapeutics
  • Mailing Address
    One Kendall Square, Building 600 Cambridge, MA 02139
  • Company Description
    Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The new investment will support further development of Pervasis’ innovative Vascugel® blood vessel repair therapeutic, presently in two Phase II clinical trials, as well as continuing research into expanding the product’s projected uses into additional vascular and non-vascular applications, including cardiovascular and other indications.
  • M&A Terms
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    Highland Capital Partners

Trending on Xconomy